Hematological disorders and pulmonary hypertension

doi:10.4330/wjc.v8.i12.703

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16813)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

1142

WORD

374

HTML

11320

Figures (1-1)

276

Sum=13112

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

441

Download

998

Sum=1439

Publishing Process of This Article

Item

Count

Browse

974

Download

1288

Sum=2262

Dec 26, 2016 (publication date) through Jan 24, 2025

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Cardiol. Dec 26, 2016; 8(12): 703-718
Published online Dec 26, 2016. doi: 10.4330/wjc.v8.i12.703

Full Size Figure Download Figure

Figure 1 Various pathways of hematological disturbances leading to pulmonary hypertension. ADMA: Asymmetric dimethylarginine; Hb: Hemoglobin; NO: Nitric oxide; Pulm. Vasc.: Pulmonary vascular.

Citation: Mathew R, Huang J, Wu JM, Fallon JT, Gewitz MH. Hematological disorders and pulmonary hypertension. World J Cardiol 2016; 8(12): 703-718
URL: https://www.wjgnet.com/1949-8462/full/v8/i12/703.htm
DOI: https://dx.doi.org/10.4330/wjc.v8.i12.703